Reduced-GCK activity lowers mRNA levels for triglyceride synthesis enzymes but also for insulin receptors, leading to insulin resistance [27,28,29], suggesting that GCK inhibition by squalene may be useful in the treatment against fatty liver. Here, GCK is linked to Insulin resistance.